Abstract: A commercially advantageous process for producing m- or p-aminobenzylamine is provided, which is characterized by subjecting m- or p-nitrobenzaldehyde and ammonia to catalytic reduction in the presence of a reducing catalyst in an organic solvent; in the reduction, when nitrobenzaldehyde and ammonia are in advance made a mixed solution in an organic solvent, and this solution is added in divided manner, the yield being further improved.

Abstract: Hydroxybenzaldoxime O-ethers of the formula ##STR1## in which R.sup.1 represents alkyl,are obtained by a process in which a tert.-butoxy-benzaldoxime of the formula ##STR2## is reacted with alkylating agents of the formulaR.sup.1 --Xin whichR.sup.1 has the abovementioned meaning andX represents halogen or OSO.sub.2 OR.sup.1,whereinR.sup.1 again has the abovementioned meaning,in the presence of a strong base and phase transfer catalyst and in the presence of a diluent at temperatures between 0.degree. C. and 50.degree. C., and the products are then treated with anhydrous acid at temperatures between 0.degree. C. and 50.degree. C.,Hydroxybenzaldoxime O-ethers can be used as intermediate products for the synthesis of compounds with a fungicidal, insecticidal and antimycotic activity. The tert.-butoxy-benzalodoxime starting material is a new compound.

Abstract: The invention relates to a process for the preparation of nitroanilines, which consists in reacting an amine RNH.sub.2, or ammonia, with 3,4-methylenedioxynitriobenzene to give the products of the formula: ##STR1## in which R denotes hydrogen, alkyl, monohydroxyalkyl or polyhydroxyalkyl, alkoxyalkyl or aminoalkyl of the formula: ##STR2## in which R.sub.1 and R.sub.2, which are identical or different, denote hydrogen, alkyl or monohydroxyalkyl or polyhydroxyalkyl and n denotes an integer from 2 to 4, or of the formula: ##STR3## in which A denotes OCH.sub.2 or ##STR4## and R.sub.1 denotes --CH.sub.2 CH.sub.2 OH or ##STR5## or their salts.

Abstract: A highly concentrated aqueous solution of a di-C.sub.6-20 alkyl methylamine oxide containing at least 50 weight percent of the amine oxide can be made without gel formation by reacting at least 40 weight percent aqueous hydrogen peroxide with a di-C.sub.6-20 alkyl methyl or ethylamine. These concentrated solutions offer large freight savings in shipping the amine oxides to remote locations.

Abstract: A process for accelerating the oxidation of tert-amines by hydrogen peroxide by conducting the reaction in the presence of an ascorbic acid promoter.

Abstract: Novel 4-phenyl-1,3-benzodiazepines and 2-amino-.alpha.-phenylphenethylamines, novel intermediates thereof, and methods of preparing same are described. These benzodiazepines are useful as antidepressants, analgetics and anticonvulsants. The 2-amino-.alpha.-phenylphenethylamines are useful as anticonvulsant and neuroprotective agents.

Abstract: A process for the preparation of squaraine compounds which comprises reacting an aromatic amine or mixtures of such amines with squaric acid or squaric acid derivatives in the presence of an aliphatic alcohol and a trialkylorthoformate.

Abstract: N-Arylpropyl-substituted secondary amines of the formula ##STR1## where R.sup.1 and R.sup.2 are each hydrogen, alkyl, cycloalkyl, haloalkyl, alkoxy, chlorine, bromine or fluorine, m is 0, 1 or 2, R.sup.3 and R.sup.4 are each hydrogen or alkyl, and R.sup.5 is alkyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, alkenyl or an unsubstituted or substituted phenyl or phenylalkyl radical or methylfuran and the dashed bonds may be hydrogenated, and their salts, and fungicides containing these compounds.

Abstract: N-benzyl-N-methyl-3,4-dimethoxyphenethylamine is prepared by reacting 3,4-dimethoxyphenethylamine with a mixture of benzaldehyde and formaldehyde in the presence of hydrogen and a catalyst such as palladium on carbon.

Abstract: The invention relates to the new N-[2-/4-fluorophenyl/-1-methyl]-ethyl-N-methyl-N-propynyl amine of the Formula I ##STR1## and isomers and salts thereof. The compound of the formula I is useful as a selective MAO inhibitor.

Abstract: Compounds of the general formulaX--Y--O--(A--O--Y--O).sub.m --A--O--Y--X (1)wherein X is a radical of the general formula[R.sup.1 --G.sub.p --(O--CHR.sup.2 --CHR.sup.3 --).sub.n ].sub.2 N--(1a)in which R.sup.1 is a saturated aliphatic radical of from 6 to 30 carbon atoms or an unsaturated aliphatic radical having one or several ethylenic bonds and being of from 6 to 30 carbon atoms, G is phenylene or naphthylene, p is zero or 1, R.sup.2 and R.sup.3 are hydrogen or methyl, but are not both methyl, and n is a number from 0 to 25, Y is a radical of the formula ##STR1## in which R.sup.2 and R.sup.3 have the indicated meanings and q represents identical or different numbers from 0 to about 200, A is a radical of the general formula ##STR2## in which R.sup.4 and R.sup.5 are hydrogen or alkyl of from 1 to 3 carbon atoms, and m is a number from zero to 5, n and q not being both zero; and their use, in particular as dispersing agents, are disclosed.

Abstract: The reaction of aqueous hydrogen peroxide with tert-amines to yield tert-amine oxides is catalyzed by the addition of a promoter amount of ammonium carbonate, ammonium bicarbonate or ammonium carbamate or mixtures thereof.

Abstract: Compound of general formula I ##STR1## and its addition salts with a pharmaceutically acceptable acid is described. The compound is prepared by reacting bis-(2-(3,4-dimethoxy-phenyl)ethyl)amine with formaldehyde in a reducing medium. The compound is effective in the treatment of cardiovascular diseases and disturbances in cerebral circulation.

Abstract: The invention relates to a new process for the preparation of nitraminodiaryl sulfoxide derivatives of the formula (I), ##STR1## wherein R and R.sup.1 represent hydrogen or alkyl having from 1 to 6 carbon atoms, andR.sup.2 is hydrogen, halogen, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms, or phenyl or thiophenyl both optionally substituted by one or more identical or different halogen(s) and/or nitro group(s).The compounds of formula (I) are pharmaceutically active, and are particularly useful in the veterinary therapy as anthelmintics. In addition they show pesticidal, particularly acaricidal, fungicidal and herbicidal properties. The invention relates also to pharmaceutical and pesticidal compositions containing as active ingredient compounds of formula (I).The compounds of formula (I), in which the substituents are as defined, with the proviso that if R.sup.2 is hydrogen and the substituent --N(R,R.sup.1) is in para-position related to the sulfoxide group, R and R.sup.

Abstract: The invention relates to a process for inverting the configuration at the optically active carbon atom (*) in compounds of the formula I ##STR1## in which A denotes a carbocyclic or heterocyclic aromatic radical and R denotes an aliphatic, cycloaliphatic or araliphatic hydrocarbon radical, by formylation, treating the resulting compounds with a strong acid or an acid halide and cleaving the oxazolinium derivatives thus obtained, by acid or alkaline hydrolysis, if appropriate via the stage of the N-formyl compound, and to oxazolinium derivatives of the formula III defined herein and formed as intermediate products.

Abstract: Products useful as surfactants, corrosion inhibitors, water repellent agents, paint adhesion promoters, etc. are prepared by reacting formaldehyde and a phenol with an alkyl amine containing internal propoxy or propoxy/ethoxy groups to thereby provide a corresponding Mannich condensate having a desired utility. The Mannich condensates may also be reacted with an alkylene oxide feed stock containing ethylene oxide or propylene oxide or 1,2-butylene oxide or a mixture thereof under conventional alkoxylation conditions to thereby provide a corresponding alkoxylated Mannich condensate having a utility which may be the same as or different from the utility of the initial Mannich condensate.

Abstract: New methylenebis(metachloro)anilines which are chain-lenghtening agents or cross-linking agents for polyurethanes.

Abstract: Hydroxyalkyl-phenoxy-propan-2-ol-3-amines are oculoselective .beta.-blockers useful in the treatment of elevated intraocular pressure with little or no effect on the pulmonary or cardiovascular system.

Abstract: The invention relates to N-phenoxyphenylisothioureas of the formula ##STR1## wherein each of R.sub.1, R.sub.2 and R.sub.3 is hydrogen, halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, trifluoromethyl or nitro, each of R.sub.4 and R.sub.5 is C.sub.2 -C.sub.4 alkyl, R.sub.6 is C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 alkenyl or C.sub.3 -C.sub.5 alkynyl, R.sub.7 is C.sub.1 -C.sub.10 alkyl, C.sub.3 -C.sub.5 alkenyl or C.sub.3 -C.sub.6 cycloalkyl, and R.sub.8 is hydrogen or C.sub.1 -C.sub.10 alkyl. The invention further relates to the production of these compounds and their use in pest control, as well as to phenoxyphenylthioureas as intermediates for the production of the N-phenoxyphenylisothioureas of the invention.

Abstract: Compounds of formula I ##STR1## wherein R.sub.1 represents a group of formula ##STR2## and R.sub.2 represents hydrogen or lower alkyl, orR.sub.1 and R.sub.2 together with the carbon atom to which they are attached represent a group of formula IIg ##STR3## R.sub.4 and R.sub.5 represent independently hydrogen or lower alkyl, R.sub.3 represents hydrogen, alkyl, cycloalkyl or halogenalkyl andR.sub.6 represents a group of formula ##STR4## R.sub.1 represents a group of formula IIa to IIf as defined above, R.sub.2 and R.sub.3 together form a --(CH.sub.2)--.sub.u group wherein u stands for a whole number from 1 to 8 and R.sub.4, R.sub.5 and R.sub.6 have the meanings given above.which compounds are indicated for use as pharmaceuticals and agrochemicals.